Case Study – Top 20 Global Pharma Company
Innovation Services
Top 20 Global Pharma
“An agile and flexible partner in early exploration; adjusting to new insights quickly and providing consolidated learnings and actionable recommendations.”
Digital Health Asset Lead
Pharma HQ
Anonymised for client privacy
Problem
This global pharma company had embarked on internal product innovation using its own in-house agile teams.
They were second to none in understanding patient needs – and rapidly building, testing and iterating to validate product features. However they required external insight into chronic digital health market opportunities, particularly in an emerging and potentially differentiated space.
Our Approach
Working alongside the client team we combined rapid desk research and profiling of existing services to develop a strong view on potential future entrants to the market and a defensible space to play.
Using internal and external data we built a TAM/TOM/SOM model to size potential market.
Team
The skills we provided:
– Senior Strategy Partner
– 2x Digital Health Strategist
– Research Lead & team
– Expert Digital Health writer
Timescales
6 weeks from project start to delivery, meeting deadlines for internal investment approval.
Outputs
– Market opportunity analysis
– Profiles of current and future competitors
– In-depth reports on current chronic disease management solutions
– Market sizing and opportunity evaluation
Benefits
The engagement enabled hypotheses development and allowed the client to move forward into Phase 2 strategic decisions.
The stakeholder was able to progress with building a business and investment case for presentation to C-suite stakeholders.
